{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:19:52Z","timestamp":1792131592362,"version":"4.4.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T00:00:00Z","timestamp":1574812800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T00:00:00Z","timestamp":1574812800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>To quantify the financial cost of pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Healthcare use was captured through data linkage, wherein clinical data for SSc patients enrolled in the Australian Scleroderma Cohort Study were linked with hospital, emergency department (ED) and ambulatory care databases (MBS) for the period 2008\u20132015. PAH was diagnosed on right heart catheter according to international criteria. Determinants of healthcare cost were estimated using logistic regression.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Total median (25th\u201375th) healthcare cost per patient (including hospital, ED and MBS cost but excluding medication cost) for our cohort during 2008\u20132015 was AUD$37,685 (18,144-78,811) with an annual per patient healthcare cost of AUD$7506 (5273-10,654). Total healthcare cost was higher for SSc-PAH patients compared with those without PAH with a total cost per patient of AUD$70,034 (37,222-110,814) vs AUD$34,325 (16,093 \u2013 69,957), <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001 respectively with an annual excess healthcare cost per PAH patient of AUD$2463 (1973-1885), <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001. The cost of SSc-PAH occurs early post PAH diagnosis with 89.4% utilizing a healthcare service within the first 12\u2009months post PAH diagnosis with an associated cost per patient of AUD$4125 (0\u201315,666). PAH severity was the main significant determinant of increased healthcare cost (OR 2.5, <jats:italic>p<\/jats:italic>\u2009=\u20090.03) in our PAH cohort.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Despite SSc-PAH being a low prevalence disease, it is associated with significant healthcare resource utilization and associated economic burden, predominantly driven by the severity of PAH.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12890-019-0989-1","type":"journal-article","created":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T16:02:56Z","timestamp":1574870576000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The economic burden of systemic sclerosis related pulmonary arterial hypertension in Australia"],"prefix":"10.1186","volume":"19","author":[{"given":"Kathleen","family":"Morrisroe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Sahhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gene-Siew","family":"Ngian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nava","family":"Ferdowsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreeya","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine L.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Roddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Proudman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandana","family":"Nikpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,27]]},"reference":[{"issue":"4","key":"989_CR1","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.semarthrit.2007.05.003","volume":"37","author":"H Chifflot","year":"2008","unstructured":"Chifflot H, Fautrel B, Sordet C, Chatelus E, Sibilia J. Incidence and prevalence of systemic sclerosis: a systematic literature review. Semin Arthritis Rheum. 2008;37(4):223\u201335.","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"989_CR2","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1002\/art.22910","volume":"57","author":"BD Thombs","year":"2007","unstructured":"Thombs BD, Taillefer SS, Hudson M, Baron M. Depression in patients with systemic sclerosis: a systematic review of the evidence. Arthritis Rheum. 2007;57(6):1089\u201397.","journal-title":"Arthritis Rheum"},{"issue":"48","key":"989_CR3","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000008503","volume":"96","author":"K Morrisroe","year":"2017","unstructured":"Morrisroe K, Stevens W, Sahhar J, Ngian GS, Rabusa C, Ferdowsi N, Hill C, Proudman S, Nikpour M. Quantifying the direct public health care cost of systemic sclerosis: a comprehensive data linkage study. Med. 2017;96(48):e8503.","journal-title":"Med"},{"issue":"2","key":"989_CR4","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3899\/jrheum.170307","volume":"45","author":"A Fischer","year":"2018","unstructured":"Fischer A, Kong AM, Swigris JJ, Cole AL, Raimundo K. All-cause healthcare costs and mortality in patients with systemic sclerosis with lung involvement. J Rheumatol. 2018;45(2):235\u201341.","journal-title":"J Rheumatol"},{"issue":"12","key":"989_CR5","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.3899\/jrheum.120600","volume":"39","author":"DE Furst","year":"2012","unstructured":"Furst DE, Fernandes AW, Iorga SR, Greth W, Bancroft T. Annual medical costs and healthcare resource use in patients with systemic sclerosis in an insured population. J Rheumatol. 2012;39(12):2303\u20139.","journal-title":"J Rheumatol"},{"issue":"10","key":"989_CR6","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1007\/s10067-013-2307-2","volume":"32","author":"X Yang","year":"2013","unstructured":"Yang X, Mardekian J, Sanders KN, Mychaskiw MA, Thomas J 3rd. Prevalence of pulmonary arterial hypertension in patients with connective tissue diseases: a systematic review of the literature. Clin Rheumatol. 2013;32(10):1519\u201331.","journal-title":"Clin Rheumatol"},{"issue":"11","key":"989_CR7","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1136\/ard.62.11.1088","volume":"62","author":"D Mukerjee","year":"2003","unstructured":"Mukerjee D, St George D, Coleiro B, Knight C, Denton CP, Davar J, Black CM, Coghlan JG. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis. 2003;62(11):1088\u201393.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"989_CR8","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1002\/art.40027","volume":"69","author":"Y Hao","year":"2017","unstructured":"Hao Y, Hudson M, Baron M, Carreira P, Stevens W, Rabusa C, Tatibouet S, Carmona L, Joven BE, Huq M, et al. Early Mortality in a Multinational Systemic Sclerosis Inception Cohort. Arthritis Rheumatol (Hoboken, NJ). 2017;69(5):1067\u201377.","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"issue":"1","key":"989_CR9","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13075-017-1341-x","volume":"19","author":"K Morrisroe","year":"2017","unstructured":"Morrisroe K, Stevens W, Huq M, Prior D, Sahhar J, Ngian GS, Celermajer D, Zochling J, Proudman S, Nikpour M. Survival and quality of life in incident systemic sclerosis-related pulmonary arterial hypertension. Arthritis Res Ther. 2017;19(1):122.","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"989_CR10","doi-asserted-by":"publisher","first-page":"343","DOI":"10.7326\/0003-4819-115-5-343","volume":"115","author":"GE D'Alonzo","year":"1991","unstructured":"D'Alonzo GE, Barst RJ, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, Goldring RM, Groves BM, Kernis JT, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med. 1991;115(5):343\u20139.","journal-title":"Ann Intern Med"},{"issue":"1","key":"989_CR11","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.berh.2016.03.004","volume":"30","author":"V Thakkar","year":"2016","unstructured":"Thakkar V, Lau EM. Connective tissue disease-related pulmonary arterial hypertension. Best Pract Res Clin Rheumatol. 2016;30(1):22\u201338.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"11","key":"989_CR12","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1080\/13696998.2017.1363049","volume":"20","author":"R Dufour","year":"2017","unstructured":"Dufour R, Pruett J, Hu N, Lickert C, Stemkowski S, Tsang Y, Lane D, Drake W 3rd. Healthcare resource utilization and costs for patients with pulmonary arterial hypertension: real-world documentation of functional class. J Med Econ. 2017;20(11):1178\u201386.","journal-title":"J Med Econ"},{"issue":"4","key":"989_CR13","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1378\/chest.15-0300","volume":"148","author":"HW Farber","year":"2015","unstructured":"Farber HW, Miller DP, Poms AD, Badesch DB, Frost AE, Muros-Le Rouzic E, Romero AJ, Benton WW, Elliott CG, McGoon MD, et al. Five-year outcomes of patients enrolled in the REVEAL registry. Chest. 2015;148(4):1043\u201354.","journal-title":"Chest"},{"key":"989_CR14","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1186\/s12913-014-0676-0","volume":"14","author":"M Sikirica","year":"2014","unstructured":"Sikirica M, Iorga SR, Bancroft T, Potash J. The economic burden of pulmonary arterial hypertension (PAH) in the US on payers and patients. BMC Health Serv Res. 2014;14:676.","journal-title":"BMC Health Serv Res"},{"issue":"3","key":"989_CR15","first-page":"291","volume":"24","author":"CD Burger","year":"2018","unstructured":"Burger CD, Pruett JA, Lickert CA, Berger A, Murphy B, Drake W 3rd. Prostacyclin use among patients with pulmonary arterial hypertension in the United States: a retrospective analysis of a large health care claims database. J Manag Care Spec Pharm. 2018;24(3):291\u2013302.","journal-title":"J Manag Care Spec Pharm"},{"issue":"3 Suppl","key":"989_CR16","first-page":"s47","volume":"21","author":"JP Burke","year":"2015","unstructured":"Burke JP, Hunsche E, Regulier E, Nagao M, Buzinec P, Drake Iii W. Characterizing pulmonary hypertension-related hospitalization costs among Medicare advantage or commercially insured patients with pulmonary arterial hypertension: a retrospective database study. Am J Manag Care. 2015;21(3 Suppl):s47\u201358.","journal-title":"Am J Manag Care"},{"issue":"11","key":"989_CR17","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","volume":"72","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger TA Jr, Carreira PE, et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative. Ann Rheum Dis. 2013;72(11):1747\u201355.","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"989_CR18","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.5603\/KP.2015.0242","volume":"73","author":"N Galie","year":"2015","unstructured":"Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, et al. 2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Kardiol Pol. 2015;73(12):1127\u2013206.","journal-title":"Kardiol Pol"},{"issue":"2","key":"989_CR19","first-page":"177","volume":"69","author":"N Galie","year":"2016","unstructured":"Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, et al. 2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Rev Esp De Cardiol (English ed). 2016;69(2):177.","journal-title":"Rev Esp De Cardiol (English ed)"},{"issue":"4","key":"989_CR20","doi-asserted-by":"publisher","first-page":"249","DOI":"10.5114\/reum.2018.77977","volume":"56","author":"M Chowaniec","year":"2018","unstructured":"Chowaniec M, Skoczynska M, Sokolik R, Wiland P. Interstitial lung disease in systemic sclerosis: challenges in early diagnosis and management. Reumatologia. 2018;56(4):249\u201354.","journal-title":"Reumatologia"},{"key":"989_CR21","doi-asserted-by":"crossref","unstructured":"Morrisroe K, Hansen D, Huq M, Stevens W, Sahhar J, Ngian GS, Ferdowsi N, Hill C, Roddy J, Walker J, et al. Incidence, risk factors and outcomes of cancer in systemic sclerosis. Arthritis Care Res. 2019.","DOI":"10.1002\/acr.24076"},{"key":"989_CR22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13075-015-0517-5","volume":"17","author":"Y Hao","year":"2015","unstructured":"Hao Y, Thakkar V, Stevens W, Morrisroe K, Prior D, Rabusa C, Youssef P, Gabbay E, Roddy J, Walker J, et al. A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis. Arthritis R Ther. 2015;17:7.","journal-title":"Arthritis R Ther"},{"issue":"5","key":"989_CR23","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1378\/chest.14-0193","volume":"146","author":"CD Burger","year":"2014","unstructured":"Burger CD, Long PK, Shah MR, McGoon MD, Miller DP, Romero AJ, Benton WW, Safford RE. Characterization of first-time hospitalizations in patients with newly diagnosed pulmonary arterial hypertension in the REVEAL registry. Chest. 2014;146(5):1263\u201373.","journal-title":"Chest"},{"issue":"5","key":"989_CR24","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1378\/chest.12-3023","volume":"144","author":"AE Frost","year":"2013","unstructured":"Frost AE, Badesch DB, Miller DP, Benza RL, Meltzer LA, McGoon MD. Evaluation of the predictive value of a clinical worsening definition using 2-year outcomes in patients with pulmonary arterial hypertension: a REVEAL registry analysis. Chest. 2013;144(5):1521\u20139.","journal-title":"Chest"},{"issue":"2","key":"989_CR25","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.chest.2019.02.004","volume":"156","author":"RL Benza","year":"2019","unstructured":"Benza RL, Gomberg-Maitland M, Elliott CG, Farber HW, Foreman AJ, Frost AE, McGoon MD, Pasta DJ, Selej M, Burger CD, et al. Predicting survival in patients with pulmonary arterial hypertension: the REVEAL risk score calculator 2.0 and comparison with ESC\/ERS-based risk assessment strategies. Chest. 2019;156(2):323\u201337.","journal-title":"Chest"},{"issue":"5","key":"989_CR26","doi-asserted-by":"publisher","first-page":"947","DOI":"10.3111\/13696998.2012.690801","volume":"15","author":"R Copher","year":"2012","unstructured":"Copher R, Cerulli A, Watkins A, Laura Monsalvo M. Treatment patterns and healthcare system burden of managed care patients with suspected pulmonary arterial hypertension in the United States. J Med Econ. 2012;15(5):947\u201355.","journal-title":"J Med Econ"},{"issue":"3","key":"989_CR27","doi-asserted-by":"publisher","first-page":"500","DOI":"10.3111\/13696998.2012.665109","volume":"15","author":"Q Said","year":"2012","unstructured":"Said Q, Martin BC, Joish VN, Kreilick C, Mathai SC. The cost to managed care of managing pulmonary hypertension. J Med Econ. 2012;15(3):500\u20138.","journal-title":"J Med Econ"},{"issue":"3","key":"989_CR28","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3111\/13696998.2010.496694","volume":"13","author":"M Angalakuditi","year":"2010","unstructured":"Angalakuditi M, Edgell E, Beardsworth A, Buysman E, Bancroft T. Treatment patterns and resource utilization and costs among patients with pulmonary arterial hypertension in the United States. J Med Econ. 2010;13(3):393\u2013402.","journal-title":"J Med Econ"},{"issue":"5","key":"989_CR29","doi-asserted-by":"publisher","first-page":"293","DOI":"10.2165\/11592430-000000000-00000","volume":"9","author":"NY Kirson","year":"2011","unstructured":"Kirson NY, Birnbaum HG, Ivanova JI, Waldman T, Joish V, Williamson T. Excess costs associated with patients with pulmonary arterial hypertension in a US privately insured population. Appl Health Econ Health Policy. 2011;9(5):293\u2013303.","journal-title":"Appl Health Econ Health Policy"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-019-0989-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12890-019-0989-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-019-0989-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T00:19:24Z","timestamp":1606349964000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-019-0989-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,27]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["989"],"URL":"https:\/\/doi.org\/10.1186\/s12890-019-0989-1","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,27]]},"assertion":[{"value":"16 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Written consent for publication was obtained from all patients at recruitment.Ethical approval for this study was obtained from all participating hospitals (St. Vincent\u2019s Hospital, Melbourne, Monash Health, Royal Adelaide Hospital, Royal Perth Hospital and Royal Hobart Hospital, Tasmania) (Human Research Ethics Committee approval number HREC-A 020\/07).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors have read and approved the final manuscript. None of the authors declare a conflict of interest or competing interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"226"}}